Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Candotti

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|December 22, 2004
CXCL12 signaling is independent of Jak2 and Jak3Masato Moriguchi, Bruce D Hissong, Massimo Gadina, et al.
Genome Research|October 31, 2013
The altered landscape of the human skin microbiome in patients with primary immunodeficienciesJulia Oh, Alexandra F Freeman, , et al.
Cell Reports|March 9, 2022
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversificationMarc Descatoire, Remi Fritzen, Samuel Rotman, et al.
Blood|May 12, 2010
Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome proteinNikolay P Nikolov, Masaki Shimizu, Sophia Cleland, et al.
Blood|April 12, 2003
In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animalsChristine S McCauslin, John Wine, Linzhao Cheng, et al.
Frontiers in Immunology|September 13, 2021
Novel Discoveries in Immune Dysregulation in Inborn Errors of ImmunityAnwen Ren, Wei Yin, Heather Miller, et al.
Blood|March 12, 2008
Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndromeBrian R Davis, Michael J Dicola, Nicole L Prokopishyn, et al.
Molecular Immunology|June 29, 2004
Jak3 and the pathogenesis of severe combined immunodeficiencyJohn J O'Shea, Matthew Husa, Denise Li, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Pharmacokinetics and organ distribution of N-methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase geneRoy Noy, Zvi Ben-Zvi, Miri Elezra, et al.
Molecular Cancer Therapeutics|December 14, 2002
Antitumor activity and metabolic activation of N-methanocarbathymidine, a novel thymidine analogue with a pseudosugar rigidly fixed in the northern conformation, in murine colon cancer cells expressing herpes simplex thymidine kinaseRoy Noy, Zvi Ben-Zvi, Esther Manor, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|December 22, 2004
CXCL12 signaling is independent of Jak2 and Jak3Masato Moriguchi, Bruce D Hissong, Massimo Gadina, et al.
Genome Research|October 31, 2013
The altered landscape of the human skin microbiome in patients with primary immunodeficienciesJulia Oh, Alexandra F Freeman, , et al.
Cell Reports|March 9, 2022
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversificationMarc Descatoire, Remi Fritzen, Samuel Rotman, et al.
Blood|May 12, 2010
Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome proteinNikolay P Nikolov, Masaki Shimizu, Sophia Cleland, et al.
Blood|April 12, 2003
In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animalsChristine S McCauslin, John Wine, Linzhao Cheng, et al.
Frontiers in Immunology|September 13, 2021
Novel Discoveries in Immune Dysregulation in Inborn Errors of ImmunityAnwen Ren, Wei Yin, Heather Miller, et al.
Blood|March 12, 2008
Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndromeBrian R Davis, Michael J Dicola, Nicole L Prokopishyn, et al.
Molecular Immunology|June 29, 2004
Jak3 and the pathogenesis of severe combined immunodeficiencyJohn J O'Shea, Matthew Husa, Denise Li, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Pharmacokinetics and organ distribution of N-methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase geneRoy Noy, Zvi Ben-Zvi, Miri Elezra, et al.
Molecular Cancer Therapeutics|December 14, 2002
Antitumor activity and metabolic activation of N-methanocarbathymidine, a novel thymidine analogue with a pseudosugar rigidly fixed in the northern conformation, in murine colon cancer cells expressing herpes simplex thymidine kinaseRoy Noy, Zvi Ben-Zvi, Esther Manor, et al.
Pageof 15